Showing 1121-1130 of 19239 results for "".
Current & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults
https://reachmd.com/programs/cme/current-emerging-therapies-treating-preventing-hereditary-angioedema-attacks-in-children-adults/37604/Provided by RMEI Medical Education, LLC. Supported by independent educational grants from Intellia Therapeutics, Pharming Healthcare, Inc., and Pharvaris.Evaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
https://reachmd.com/programs/medical-industry-feature/evaluating-efs-and-surgical-outcomes-in-resectable-nsclc-insights-from-a-clinical-trial/39813/GA Case Compendium: Identification of Geographic Atrophy on Color Fundus Photography
https://reachmd.com/resources/geographic-atrophy-case-compendium/ga-case-compendium-identification-of-geographic-atrophy-on-color-fundus-photography/56702/The Regulatory Environment for the Artificial Pancreas
https://reachmd.com/programs/diabetes-discourse/the-regulatory-environment-for-the-artificial-pancreas/6500/The artificial pancreas project lead by the Juvenile Diabetes Research Foundation has made tremendous progress towards eventual outpatient clinical studies. A recent panel of experts met with the FDA and NIH to determine appropriate guidelines. What are regulatory guidelines for the artificial panOral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
https://reachmd.com/programs/project-oncology/oral-contraceptives-and-endometrial-cancer-examining-a-potential-dose-response-protective-effect/35506/As rates of endometrial cancer rise globally, a 2025 meta-analysis offers compelling evidence that oral contraceptives (OCs) could significantly reduce EMC risk. Explore the findings from this new review and its potential implications for the future of patient care.MS Minute: Disparities in Multiple Sclerosis: Incorporating Equity Into Clinical Care and Research
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-disparities-in-multiple-sclerosis-incorporating-equity-into-clinical-care-and-research/32018/Assessing biologic, genetic, and social factors of patients with MS to shrink the gap in care for underrepresented populations.Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
https://reachmd.com/programs/project-oncology/ibrutinib-venetoclax-in-relapsed-cll-mrd-guided-approach-balances-efficacy-and-safety/37206/Measuring IgAN Risk: Genetic, Environmental, and Systemic Factors
https://reachmd.com/programs/clinicians-roundtable/measuring-igan-risk-genetic-environmental-and-systemic-factors/29742/Learn about common risk factors for IgA nephropathy.Deciphering IgA Nephropathy: Insights into the Diagnostic Process
https://reachmd.com/programs/frontlines-iga-nephropathy/deciphering-iga-nephropathy-insights-into-the-diagnostic-process/26946/When IgA nephropathy is suspected, it’s important to follow a stepwise pattern to confirm those suspicions. Here’s what the diagnostic process looks like.AI and Hair Loss: Measuring Progress with Data-Driven Insights
https://reachmd.com/programs/clinicians-roundtable/ai-and-hair-loss-measuring-progress-with-data-driven-insights/32933/Explore how devices powered by artificial intelligence can impact the way dermatologists track hair loss through precise data.